Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-07-06FDA Approved: DICLOFENAC SODIUM — Supplemental Application (Edenbridge Pharmaceuticals LLC.)
FDA approved a supplemental application for diclofenac sodium from Edenbridge Pharmaceuticals LLC under the ANDA program. This action consti…
-
FDA approval · 2010-06-03FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
The FDA approved a supplemental application for Enbrel (etanercept) submitted by Immunex Corporation.
-
FDA approval · 2010-04-26FDA Approved: ZYBIC — Supplemental Application (Redmont Pharmaceuticals, LLC)
FDA approved a supplemental application for ZYBIC (meloxicam) submitted by Redmont Pharmaceuticals, LLC.
-
FDA approval · 2010-03-19FDA Approved: DICLOFENAC SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for diclofenac sodium from Aurobindo Pharma Limited. This action authorizes changes to the approved …
-
FDA approval · 2010-03-17FDA Approved: INDOMETHACIN — Original Application (Fresenius Kabi USA, LLC)
The FDA approved an original NDA for indomethacin from Fresenius Kabi USA, LLC. The approval covers indications for inflammatory and musculo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-01-08FDA Approved: ACTEMRA — Original Application (Genentech, Inc.)
FDA approved ACTEMRA (tocilizumab) under its original Biologics License Application from Genentech, for rheumatoid arthritis.
-
FDA approval · 2009-10-19FDA Approved: AZULFIDINE EN-TABS — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Azulfidine EN-Tabs (sulfasalazine) from Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2009-10-16FDA Approved: RITUXAN — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Rituxan (rituximab) from Genentech.
-
FDA approval · 2009-10-08FDA Approved: NEORAL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for NEORAL (cyclosporine) from Novartis Pharmaceuticals Corporation.
-
FDA approval · 2009-10-01FDA Approved: SULINDAC — Supplemental Application (PuraCap Laboratories LLC dba Blu Pharmaceuticals)
FDA approved a supplemental application for the generic NSAID sulindac from PuraCap Laboratories LLC dba Blu Pharmaceuticals (ANDA072711).
-
FDA approval · 2009-09-24FDA Approved: MELOXICAM — Supplemental Application (Carlsbad Technology, Inc.)
The FDA approved a supplemental application for Meloxicam from Carlsbad Technology, Inc., indicating the supplemental action for the generic…
-
FDA approval · 2009-09-24FDA Approved: NEORAL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for NEORAL (cyclosporine) from Novartis Pharmaceuticals Corporation, authorizing changes to the …
-
FDA approval · 2009-05-13FDA Approved: CIMZIA — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for CIMZIA (certolizumab pegol) submitted by UCB, Inc.
-
FDA approval · 2009-04-24FDA Approved: SIMPONI — Original Application (Janssen Biotech, Inc.)
FDA approved the original Biologics License Application for Simponi (golimumab) from Janssen Biotech, Inc.
-
FDA approval · 2009-04-03FDA Approved: ARAVA — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for ARAVA (leflunomide) from Sanofi-Aventis U.S. LLC, authorizing changes to the product's label…
-
FDA approval · 2009-03-24FDA Approved: IBUPROFEN — Original Application (DOLGENCORP INC)
The FDA approved DolGenCorp Inc's original application for ibuprofen, establishing a generic ibuprofen product (capsules, including liquid-f…
-
FDA approval · 2009-03-06FDA Approved: INDOMETHACIN — Original Application (KVK-Tech, Inc.)
FDA approved an original application for Indomethacin by KVK-Tech, Inc., establishing a generic version of indomethacin. The approval signif…
-
FDA approval · 2009-01-14FDA Approved: ETODOLAC — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
The FDA approved a supplemental application for etodolac by Taro Pharmaceuticals U.S.A., Inc. under the ANDA program.
-
FDA approval · 2009-01-14FDA Approved: ETODOLAC — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
FDA approved a supplemental application for etodolac filed by Taro Pharmaceuticals U.S.A., Inc., authorizing changes to labeling and/or manu…
-
FDA approval · 2008-10-29FDA Approved: NAPROXEN — Supplemental Application (Granules India Ltd)
FDA approved a supplemental application from Granules India Ltd for Naproxen (Naproxen sodium) granules. This adds a granulated dosage form …
-
FDA approval · 2008-09-24FDA Approved: NABUMETONE — Original Application (ScieGen Pharmaceuticals Inc)
FDA approves ScieGen Pharmaceuticals Inc's Nabumetone as a generic product under an Original Application (ANDA), marking its regulatory appr…
-
FDA approval · 2008-07-31FDA Approved: TOLMETIN SODIUM — Supplemental Application (Atland Pharmaceuticals, LLC)
FDA approved a supplemental application for Tolmetin Sodium from Atland Pharmaceuticals, LLC.
-
FDA approval · 2008-07-25FDA Approved: NAPROXEN — Supplemental Application (Zameer Pharmaceuticals LLC)
The FDA has approved a supplemental application for naproxen filed by Zameer Pharmaceuticals LLC.
-
FDA approval · 2008-06-20FDA Approved: JUNIOR STRENGTH ADVIL — Supplemental Application (Haleon US Holdings LLC)
FDA approves a supplemental application for JUNIOR STRENGTH ADVIL (ibuprofen) from Haleon US Holdings LLC.
-
CLINICAL_TRIALS approval · 2008-04-14Clinical Trial Update: Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid Arthritis
Adalimumab has received marketing approval for active rheumatoid arthritis under an early access program.